Notable Quotes
We're seeing that patients with pre-existing advanced left ventricular enlargement benefit most—this tells us we can stratify who should receive this therapy.
Louis Lemberg Professor of Medicine, Director of Interdisciplinary Stem Cell Institute
Appears in 1 story
We're seeing that patients with pre-existing advanced left ventricular enlargement benefit most—this tells us we can stratify who should receive this therapy.